Match each patient's clinical presentation and laboratory profile with the most likely underlying renal mechanism responsible for the derangements.
- A 55-year-old treated for essential hypertension has asymptomatic laboratory findings of 2.8 mEq/L, 32 mEq/L, and a 24-hour urine calcium of 75 mg.Inhibition of the - cotransporter in the distal convoluted tubule
- A 60-year-old treated for decompensated heart failure develops leg cramps; labs show 3.0 mEq/L, 31 mEq/L, and a 24-hour urine calcium of 350 mg.Inhibition of the -- cotransporter in the thick ascending limb
- A 45-year-old with a psychiatric history complains of profound thirst; labs show 149 mEq/L, serum osmolality 312 mOsm/kg, and urine osmolality 140 mOsm/kg despite water deprivation.Downregulation of aquaporin-2 channels in the principal cells of the collecting duct
- A 35-year-old receiving intravenous therapy for cryptococcal meningitis develops 139 mEq/L, 2.7 mEq/L, 14 mEq/L, 113 mEq/L, and a urine pH of 6.5.Formation of pores in the distal tubular membrane leading to increased proton permeability
Answer
Each clinical presentation connects to a distinct pharmacological etiology. The hypocalciuric patient matches the distal convoluted tubule mechanism (thiazide). The hypercalciuric patient matches the thick ascending limb mechanism (loop diuretic). The patient with dilute polyuria matches collecting duct resistance (lithium). The patient with normal anion gap metabolic acidosis and high urine pH matches distal tubule proton back-leak (Amphotericin B).
The matching requires connecting classic laboratory derangements to the specific site and mechanism of action of drugs in the nephron, utilizing distinguishing features like urine calcium levels, osmolality, and acid-base status.
Step-by-Step Solution
Key Concept
Specific pharmacological agents produce distinct renal syndromes based on their molecular mechanisms: thiazides cause hypocalciuria, loop diuretics cause hypercalciuria, lithium causes nephrogenic diabetes insipidus, and Amphotericin B causes Type 1 renal tubular acidosis.